NasdaqCM - Nasdaq Real Time Price
USD
Liminatus Pharma, Inc. (LIMN)
2.8100
+0.0600
(+2.18%)
As of 12:51:34 PM EST. Market Open.
Loading chart for LIMN
- Previous Close
2.7500 - Open
2.9700 - Bid 2.3900 x 100
- Ask 3.2500 x 100
- Day's Range
2.7936 - 2.9700 - 52 Week Range
2.7500 - 141.5000 - Volume
19,348 - Avg. Volume
221,939 - Market Cap (intraday)
3.774M - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
-- - EPS (TTM)
-23.5000 - Earnings Date --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
LIMN
90.79%
S&P 500 (^GSPC)
10.74%
1-Year Return
LIMN
95.96%
S&P 500 (^GSPC)
10.83%
3-Year Return
LIMN
99.39%
S&P 500 (^GSPC)
75.57%
5-Year Return
LIMN
99.39%
S&P 500 (^GSPC)
63.71%
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-95.65%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-12.52M
-
Diluted EPS (ttm)
-23.5000
Balance Sheet and Cash Flow
-
Total Cash (mrq)
3.02M
-
Total Debt/Equity (mrq)
479.85%
-
Levered Free Cash Flow (ttm)
-10.01M
